nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—SLC6A14—female reproductive system—uterine cancer	0.0164	0.277	CbGeAlD
Valganciclovir—SLC15A1—epithelium—uterine cancer	0.00555	0.0939	CbGeAlD
Valganciclovir—SLC15A1—renal system—uterine cancer	0.00515	0.0871	CbGeAlD
Valganciclovir—SLC15A1—endometrium—uterine cancer	0.00498	0.0842	CbGeAlD
Valganciclovir—SLC15A1—mammalian vulva—uterine cancer	0.00482	0.0815	CbGeAlD
Valganciclovir—SLC15A1—vagina—uterine cancer	0.00373	0.0631	CbGeAlD
Valganciclovir—SLC15A2—uterine cervix—uterine cancer	0.00344	0.0582	CbGeAlD
Valganciclovir—SLC15A2—renal system—uterine cancer	0.00322	0.0545	CbGeAlD
Valganciclovir—SLC15A2—endometrium—uterine cancer	0.00311	0.0526	CbGeAlD
Valganciclovir—SLC15A2—female reproductive system—uterine cancer	0.00258	0.0436	CbGeAlD
Valganciclovir—SLC15A2—female gonad—uterine cancer	0.00235	0.0397	CbGeAlD
Valganciclovir—SLC15A2—vagina—uterine cancer	0.00233	0.0394	CbGeAlD
Valganciclovir—SLC15A2—lymph node—uterine cancer	0.00151	0.0255	CbGeAlD
Valganciclovir—Nasopharyngitis—Epirubicin—uterine cancer	0.000753	0.0008	CcSEcCtD
Valganciclovir—Hypersensitivity—Dactinomycin—uterine cancer	0.000751	0.000799	CcSEcCtD
Valganciclovir—Gastritis—Epirubicin—uterine cancer	0.000745	0.000792	CcSEcCtD
Valganciclovir—Confusional state—Etoposide—uterine cancer	0.000744	0.000791	CcSEcCtD
Valganciclovir—Anaphylactic shock—Etoposide—uterine cancer	0.000738	0.000785	CcSEcCtD
Valganciclovir—Infection—Etoposide—uterine cancer	0.000733	0.00078	CcSEcCtD
Valganciclovir—Abdominal distension—Epirubicin—uterine cancer	0.000733	0.000779	CcSEcCtD
Valganciclovir—Ataxia—Doxorubicin—uterine cancer	0.000733	0.000779	CcSEcCtD
Valganciclovir—Asthenia—Dactinomycin—uterine cancer	0.000732	0.000778	CcSEcCtD
Valganciclovir—Blood creatinine increased—Doxorubicin—uterine cancer	0.00073	0.000776	CcSEcCtD
Valganciclovir—Dysphagia—Epirubicin—uterine cancer	0.000728	0.000773	CcSEcCtD
Valganciclovir—Influenza—Epirubicin—uterine cancer	0.000728	0.000773	CcSEcCtD
Valganciclovir—Dehydration—Doxorubicin—uterine cancer	0.000724	0.00077	CcSEcCtD
Valganciclovir—Thrombocytopenia—Etoposide—uterine cancer	0.000723	0.000768	CcSEcCtD
Valganciclovir—Tachycardia—Etoposide—uterine cancer	0.00072	0.000766	CcSEcCtD
Valganciclovir—Eosinophilia—Epirubicin—uterine cancer	0.00072	0.000766	CcSEcCtD
Valganciclovir—Skin disorder—Etoposide—uterine cancer	0.000717	0.000762	CcSEcCtD
Valganciclovir—Dry skin—Doxorubicin—uterine cancer	0.000714	0.000759	CcSEcCtD
Valganciclovir—Hyperhidrosis—Etoposide—uterine cancer	0.000714	0.000759	CcSEcCtD
Valganciclovir—Pancreatitis—Epirubicin—uterine cancer	0.000713	0.000758	CcSEcCtD
Valganciclovir—Abdominal pain upper—Doxorubicin—uterine cancer	0.000712	0.000756	CcSEcCtD
Valganciclovir—Hypokalaemia—Doxorubicin—uterine cancer	0.000709	0.000754	CcSEcCtD
Valganciclovir—Anorexia—Etoposide—uterine cancer	0.000704	0.000748	CcSEcCtD
Valganciclovir—Bronchitis—Epirubicin—uterine cancer	0.0007	0.000744	CcSEcCtD
Valganciclovir—Diarrhoea—Dactinomycin—uterine cancer	0.000698	0.000742	CcSEcCtD
Valganciclovir—Nasopharyngitis—Doxorubicin—uterine cancer	0.000697	0.00074	CcSEcCtD
Valganciclovir—Pancytopenia—Epirubicin—uterine cancer	0.000691	0.000735	CcSEcCtD
Valganciclovir—Hypotension—Etoposide—uterine cancer	0.00069	0.000733	CcSEcCtD
Valganciclovir—Gastritis—Doxorubicin—uterine cancer	0.000689	0.000733	CcSEcCtD
Valganciclovir—Dysuria—Epirubicin—uterine cancer	0.00068	0.000723	CcSEcCtD
Valganciclovir—Neutropenia—Epirubicin—uterine cancer	0.00068	0.000723	CcSEcCtD
Valganciclovir—Abdominal distension—Doxorubicin—uterine cancer	0.000678	0.00072	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000676	0.000719	CcSEcCtD
Valganciclovir—Influenza—Doxorubicin—uterine cancer	0.000673	0.000716	CcSEcCtD
Valganciclovir—Dysphagia—Doxorubicin—uterine cancer	0.000673	0.000716	CcSEcCtD
Valganciclovir—Pollakiuria—Epirubicin—uterine cancer	0.000672	0.000714	CcSEcCtD
Valganciclovir—Eosinophilia—Doxorubicin—uterine cancer	0.000667	0.000709	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Epirubicin—uterine cancer	0.000664	0.000706	CcSEcCtD
Valganciclovir—Paraesthesia—Etoposide—uterine cancer	0.000663	0.000705	CcSEcCtD
Valganciclovir—Pancreatitis—Doxorubicin—uterine cancer	0.00066	0.000702	CcSEcCtD
Valganciclovir—Weight decreased—Epirubicin—uterine cancer	0.000658	0.0007	CcSEcCtD
Valganciclovir—Dyspnoea—Etoposide—uterine cancer	0.000658	0.0007	CcSEcCtD
Valganciclovir—Hyperglycaemia—Epirubicin—uterine cancer	0.000656	0.000698	CcSEcCtD
Valganciclovir—Somnolence—Etoposide—uterine cancer	0.000656	0.000698	CcSEcCtD
Valganciclovir—Pneumonia—Epirubicin—uterine cancer	0.000653	0.000694	CcSEcCtD
Valganciclovir—Infestation NOS—Epirubicin—uterine cancer	0.000649	0.00069	CcSEcCtD
Valganciclovir—Infestation—Epirubicin—uterine cancer	0.000649	0.00069	CcSEcCtD
Valganciclovir—Vomiting—Dactinomycin—uterine cancer	0.000649	0.000689	CcSEcCtD
Valganciclovir—Bronchitis—Doxorubicin—uterine cancer	0.000648	0.000688	CcSEcCtD
Valganciclovir—Decreased appetite—Etoposide—uterine cancer	0.000642	0.000682	CcSEcCtD
Valganciclovir—Pancytopenia—Doxorubicin—uterine cancer	0.000639	0.00068	CcSEcCtD
Valganciclovir—Renal failure—Epirubicin—uterine cancer	0.000638	0.000678	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000637	0.000677	CcSEcCtD
Valganciclovir—Fatigue—Etoposide—uterine cancer	0.000636	0.000676	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Epirubicin—uterine cancer	0.000636	0.000676	CcSEcCtD
Valganciclovir—Jaundice—Epirubicin—uterine cancer	0.000632	0.000672	CcSEcCtD
Valganciclovir—Stomatitis—Epirubicin—uterine cancer	0.000632	0.000672	CcSEcCtD
Valganciclovir—Pain—Etoposide—uterine cancer	0.000631	0.000671	CcSEcCtD
Valganciclovir—Constipation—Etoposide—uterine cancer	0.000631	0.000671	CcSEcCtD
Valganciclovir—Urinary tract infection—Epirubicin—uterine cancer	0.000631	0.00067	CcSEcCtD
Valganciclovir—Dysuria—Doxorubicin—uterine cancer	0.00063	0.000669	CcSEcCtD
Valganciclovir—Neutropenia—Doxorubicin—uterine cancer	0.00063	0.000669	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000626	0.000665	CcSEcCtD
Valganciclovir—Pollakiuria—Doxorubicin—uterine cancer	0.000622	0.000661	CcSEcCtD
Valganciclovir—Haematuria—Epirubicin—uterine cancer	0.000619	0.000658	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000615	0.000653	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Epirubicin—uterine cancer	0.000614	0.000652	CcSEcCtD
Valganciclovir—Weight decreased—Doxorubicin—uterine cancer	0.000609	0.000647	CcSEcCtD
Valganciclovir—Sinusitis—Epirubicin—uterine cancer	0.000609	0.000647	CcSEcCtD
Valganciclovir—Feeling abnormal—Etoposide—uterine cancer	0.000608	0.000647	CcSEcCtD
Valganciclovir—Hyperglycaemia—Doxorubicin—uterine cancer	0.000607	0.000646	CcSEcCtD
Valganciclovir—Nausea—Dactinomycin—uterine cancer	0.000606	0.000644	CcSEcCtD
Valganciclovir—Pneumonia—Doxorubicin—uterine cancer	0.000604	0.000642	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Etoposide—uterine cancer	0.000604	0.000642	CcSEcCtD
Valganciclovir—Infestation—Doxorubicin—uterine cancer	0.0006	0.000638	CcSEcCtD
Valganciclovir—Infestation NOS—Doxorubicin—uterine cancer	0.0006	0.000638	CcSEcCtD
Valganciclovir—Renal failure—Doxorubicin—uterine cancer	0.00059	0.000627	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000588	0.000625	CcSEcCtD
Valganciclovir—Urticaria—Etoposide—uterine cancer	0.000586	0.000623	CcSEcCtD
Valganciclovir—Haemoglobin—Epirubicin—uterine cancer	0.000585	0.000622	CcSEcCtD
Valganciclovir—Stomatitis—Doxorubicin—uterine cancer	0.000585	0.000622	CcSEcCtD
Valganciclovir—Jaundice—Doxorubicin—uterine cancer	0.000585	0.000622	CcSEcCtD
Valganciclovir—Body temperature increased—Etoposide—uterine cancer	0.000584	0.00062	CcSEcCtD
Valganciclovir—Abdominal pain—Etoposide—uterine cancer	0.000584	0.00062	CcSEcCtD
Valganciclovir—Urinary tract infection—Doxorubicin—uterine cancer	0.000584	0.00062	CcSEcCtD
Valganciclovir—Haemorrhage—Epirubicin—uterine cancer	0.000582	0.000619	CcSEcCtD
Valganciclovir—Hepatitis—Epirubicin—uterine cancer	0.000582	0.000619	CcSEcCtD
Valganciclovir—Pharyngitis—Epirubicin—uterine cancer	0.000578	0.000614	CcSEcCtD
Valganciclovir—Urinary tract disorder—Epirubicin—uterine cancer	0.000575	0.000611	CcSEcCtD
Valganciclovir—Oedema peripheral—Epirubicin—uterine cancer	0.000574	0.00061	CcSEcCtD
Valganciclovir—Haematuria—Doxorubicin—uterine cancer	0.000572	0.000608	CcSEcCtD
Valganciclovir—Connective tissue disorder—Epirubicin—uterine cancer	0.000572	0.000608	CcSEcCtD
Valganciclovir—Urethral disorder—Epirubicin—uterine cancer	0.000571	0.000607	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000568	0.000603	CcSEcCtD
Valganciclovir—Sinusitis—Doxorubicin—uterine cancer	0.000563	0.000599	CcSEcCtD
Valganciclovir—Visual impairment—Epirubicin—uterine cancer	0.000561	0.000597	CcSEcCtD
Valganciclovir—Eye disorder—Epirubicin—uterine cancer	0.000544	0.000579	CcSEcCtD
Valganciclovir—Hypersensitivity—Etoposide—uterine cancer	0.000544	0.000578	CcSEcCtD
Valganciclovir—Tinnitus—Epirubicin—uterine cancer	0.000543	0.000577	CcSEcCtD
Valganciclovir—Haemoglobin—Doxorubicin—uterine cancer	0.000542	0.000576	CcSEcCtD
Valganciclovir—Cardiac disorder—Epirubicin—uterine cancer	0.000541	0.000575	CcSEcCtD
Valganciclovir—Hepatitis—Doxorubicin—uterine cancer	0.000539	0.000573	CcSEcCtD
Valganciclovir—Haemorrhage—Doxorubicin—uterine cancer	0.000539	0.000573	CcSEcCtD
Valganciclovir—Pharyngitis—Doxorubicin—uterine cancer	0.000535	0.000569	CcSEcCtD
Valganciclovir—Urinary tract disorder—Doxorubicin—uterine cancer	0.000532	0.000566	CcSEcCtD
Valganciclovir—Oedema peripheral—Doxorubicin—uterine cancer	0.000531	0.000564	CcSEcCtD
Valganciclovir—Asthenia—Etoposide—uterine cancer	0.00053	0.000563	CcSEcCtD
Valganciclovir—Connective tissue disorder—Doxorubicin—uterine cancer	0.00053	0.000563	CcSEcCtD
Valganciclovir—Angiopathy—Epirubicin—uterine cancer	0.000528	0.000562	CcSEcCtD
Valganciclovir—Urethral disorder—Doxorubicin—uterine cancer	0.000528	0.000562	CcSEcCtD
Valganciclovir—Immune system disorder—Epirubicin—uterine cancer	0.000526	0.000559	CcSEcCtD
Valganciclovir—Mediastinal disorder—Epirubicin—uterine cancer	0.000525	0.000558	CcSEcCtD
Valganciclovir—Chills—Epirubicin—uterine cancer	0.000523	0.000555	CcSEcCtD
Valganciclovir—Pruritus—Etoposide—uterine cancer	0.000522	0.000555	CcSEcCtD
Valganciclovir—Arrhythmia—Epirubicin—uterine cancer	0.00052	0.000553	CcSEcCtD
Valganciclovir—Visual impairment—Doxorubicin—uterine cancer	0.000519	0.000552	CcSEcCtD
Valganciclovir—Alopecia—Epirubicin—uterine cancer	0.000515	0.000547	CcSEcCtD
Valganciclovir—Mental disorder—Epirubicin—uterine cancer	0.00051	0.000542	CcSEcCtD
Valganciclovir—Malnutrition—Epirubicin—uterine cancer	0.000507	0.000539	CcSEcCtD
Valganciclovir—Diarrhoea—Etoposide—uterine cancer	0.000505	0.000537	CcSEcCtD
Valganciclovir—Eye disorder—Doxorubicin—uterine cancer	0.000504	0.000535	CcSEcCtD
Valganciclovir—Tinnitus—Doxorubicin—uterine cancer	0.000502	0.000534	CcSEcCtD
Valganciclovir—Cardiac disorder—Doxorubicin—uterine cancer	0.0005	0.000532	CcSEcCtD
Valganciclovir—Flatulence—Epirubicin—uterine cancer	0.0005	0.000531	CcSEcCtD
Valganciclovir—Tension—Epirubicin—uterine cancer	0.000498	0.000529	CcSEcCtD
Valganciclovir—Dysgeusia—Epirubicin—uterine cancer	0.000497	0.000528	CcSEcCtD
Valganciclovir—Nervousness—Epirubicin—uterine cancer	0.000492	0.000523	CcSEcCtD
Valganciclovir—Back pain—Epirubicin—uterine cancer	0.00049	0.000521	CcSEcCtD
Valganciclovir—Angiopathy—Doxorubicin—uterine cancer	0.000489	0.00052	CcSEcCtD
Valganciclovir—Dizziness—Etoposide—uterine cancer	0.000488	0.000519	CcSEcCtD
Valganciclovir—Muscle spasms—Epirubicin—uterine cancer	0.000487	0.000518	CcSEcCtD
Valganciclovir—Immune system disorder—Doxorubicin—uterine cancer	0.000487	0.000517	CcSEcCtD
Valganciclovir—Mediastinal disorder—Doxorubicin—uterine cancer	0.000486	0.000516	CcSEcCtD
Valganciclovir—Chills—Doxorubicin—uterine cancer	0.000484	0.000514	CcSEcCtD
Valganciclovir—Arrhythmia—Doxorubicin—uterine cancer	0.000481	0.000512	CcSEcCtD
Valganciclovir—Vision blurred—Epirubicin—uterine cancer	0.000478	0.000508	CcSEcCtD
Valganciclovir—Alopecia—Doxorubicin—uterine cancer	0.000476	0.000506	CcSEcCtD
Valganciclovir—Mental disorder—Doxorubicin—uterine cancer	0.000472	0.000502	CcSEcCtD
Valganciclovir—Ill-defined disorder—Epirubicin—uterine cancer	0.00047	0.0005	CcSEcCtD
Valganciclovir—Vomiting—Etoposide—uterine cancer	0.000469	0.000499	CcSEcCtD
Valganciclovir—Malnutrition—Doxorubicin—uterine cancer	0.000469	0.000499	CcSEcCtD
Valganciclovir—Anaemia—Epirubicin—uterine cancer	0.000469	0.000498	CcSEcCtD
Valganciclovir—Agitation—Epirubicin—uterine cancer	0.000466	0.000495	CcSEcCtD
Valganciclovir—Dermatitis—Etoposide—uterine cancer	0.000465	0.000494	CcSEcCtD
Valganciclovir—Headache—Etoposide—uterine cancer	0.000462	0.000492	CcSEcCtD
Valganciclovir—Flatulence—Doxorubicin—uterine cancer	0.000462	0.000491	CcSEcCtD
Valganciclovir—Tension—Doxorubicin—uterine cancer	0.00046	0.000489	CcSEcCtD
Valganciclovir—Dysgeusia—Doxorubicin—uterine cancer	0.000459	0.000488	CcSEcCtD
Valganciclovir—Malaise—Epirubicin—uterine cancer	0.000457	0.000486	CcSEcCtD
Valganciclovir—Nervousness—Doxorubicin—uterine cancer	0.000456	0.000484	CcSEcCtD
Valganciclovir—Vertigo—Epirubicin—uterine cancer	0.000456	0.000484	CcSEcCtD
Valganciclovir—Leukopenia—Epirubicin—uterine cancer	0.000454	0.000482	CcSEcCtD
Valganciclovir—Back pain—Doxorubicin—uterine cancer	0.000454	0.000482	CcSEcCtD
Valganciclovir—Muscle spasms—Doxorubicin—uterine cancer	0.000451	0.000479	CcSEcCtD
Valganciclovir—Cough—Epirubicin—uterine cancer	0.000442	0.00047	CcSEcCtD
Valganciclovir—Vision blurred—Doxorubicin—uterine cancer	0.000442	0.00047	CcSEcCtD
Valganciclovir—Convulsion—Epirubicin—uterine cancer	0.000439	0.000467	CcSEcCtD
Valganciclovir—Nausea—Etoposide—uterine cancer	0.000438	0.000466	CcSEcCtD
Valganciclovir—Hypertension—Epirubicin—uterine cancer	0.000438	0.000465	CcSEcCtD
Valganciclovir—Ill-defined disorder—Doxorubicin—uterine cancer	0.000435	0.000463	CcSEcCtD
Valganciclovir—Anaemia—Doxorubicin—uterine cancer	0.000434	0.000461	CcSEcCtD
Valganciclovir—Arthralgia—Epirubicin—uterine cancer	0.000432	0.000459	CcSEcCtD
Valganciclovir—Agitation—Doxorubicin—uterine cancer	0.000431	0.000458	CcSEcCtD
Valganciclovir—Anxiety—Epirubicin—uterine cancer	0.00043	0.000457	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000429	0.000456	CcSEcCtD
Valganciclovir—Discomfort—Epirubicin—uterine cancer	0.000426	0.000453	CcSEcCtD
Valganciclovir—Malaise—Doxorubicin—uterine cancer	0.000423	0.00045	CcSEcCtD
Valganciclovir—Dry mouth—Epirubicin—uterine cancer	0.000422	0.000449	CcSEcCtD
Valganciclovir—Vertigo—Doxorubicin—uterine cancer	0.000422	0.000448	CcSEcCtD
Valganciclovir—Leukopenia—Doxorubicin—uterine cancer	0.00042	0.000446	CcSEcCtD
Valganciclovir—Confusional state—Epirubicin—uterine cancer	0.000417	0.000443	CcSEcCtD
Valganciclovir—Anaphylactic shock—Epirubicin—uterine cancer	0.000414	0.00044	CcSEcCtD
Valganciclovir—Oedema—Epirubicin—uterine cancer	0.000414	0.00044	CcSEcCtD
Valganciclovir—Infection—Epirubicin—uterine cancer	0.000411	0.000437	CcSEcCtD
Valganciclovir—Cough—Doxorubicin—uterine cancer	0.000409	0.000435	CcSEcCtD
Valganciclovir—Convulsion—Doxorubicin—uterine cancer	0.000406	0.000432	CcSEcCtD
Valganciclovir—Nervous system disorder—Epirubicin—uterine cancer	0.000406	0.000431	CcSEcCtD
Valganciclovir—Thrombocytopenia—Epirubicin—uterine cancer	0.000405	0.000431	CcSEcCtD
Valganciclovir—Hypertension—Doxorubicin—uterine cancer	0.000405	0.000431	CcSEcCtD
Valganciclovir—Tachycardia—Epirubicin—uterine cancer	0.000404	0.000429	CcSEcCtD
Valganciclovir—Skin disorder—Epirubicin—uterine cancer	0.000402	0.000427	CcSEcCtD
Valganciclovir—Hyperhidrosis—Epirubicin—uterine cancer	0.0004	0.000425	CcSEcCtD
Valganciclovir—Arthralgia—Doxorubicin—uterine cancer	0.000399	0.000425	CcSEcCtD
Valganciclovir—Anxiety—Doxorubicin—uterine cancer	0.000398	0.000423	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000397	0.000422	CcSEcCtD
Valganciclovir—Discomfort—Doxorubicin—uterine cancer	0.000395	0.000419	CcSEcCtD
Valganciclovir—Anorexia—Epirubicin—uterine cancer	0.000394	0.000419	CcSEcCtD
Valganciclovir—Dry mouth—Doxorubicin—uterine cancer	0.000391	0.000415	CcSEcCtD
Valganciclovir—Hypotension—Epirubicin—uterine cancer	0.000387	0.000411	CcSEcCtD
Valganciclovir—Confusional state—Doxorubicin—uterine cancer	0.000386	0.00041	CcSEcCtD
Valganciclovir—Anaphylactic shock—Doxorubicin—uterine cancer	0.000383	0.000407	CcSEcCtD
Valganciclovir—Oedema—Doxorubicin—uterine cancer	0.000383	0.000407	CcSEcCtD
Valganciclovir—Infection—Doxorubicin—uterine cancer	0.00038	0.000404	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000377	0.000401	CcSEcCtD
Valganciclovir—Nervous system disorder—Doxorubicin—uterine cancer	0.000375	0.000399	CcSEcCtD
Valganciclovir—Thrombocytopenia—Doxorubicin—uterine cancer	0.000375	0.000398	CcSEcCtD
Valganciclovir—Insomnia—Epirubicin—uterine cancer	0.000374	0.000398	CcSEcCtD
Valganciclovir—Tachycardia—Doxorubicin—uterine cancer	0.000374	0.000397	CcSEcCtD
Valganciclovir—Skin disorder—Doxorubicin—uterine cancer	0.000372	0.000395	CcSEcCtD
Valganciclovir—Paraesthesia—Epirubicin—uterine cancer	0.000372	0.000395	CcSEcCtD
Valganciclovir—Hyperhidrosis—Doxorubicin—uterine cancer	0.00037	0.000393	CcSEcCtD
Valganciclovir—Dyspnoea—Epirubicin—uterine cancer	0.000369	0.000392	CcSEcCtD
Valganciclovir—Somnolence—Epirubicin—uterine cancer	0.000368	0.000391	CcSEcCtD
Valganciclovir—Anorexia—Doxorubicin—uterine cancer	0.000365	0.000388	CcSEcCtD
Valganciclovir—Dyspepsia—Epirubicin—uterine cancer	0.000364	0.000387	CcSEcCtD
Valganciclovir—Decreased appetite—Epirubicin—uterine cancer	0.00036	0.000382	CcSEcCtD
Valganciclovir—Hypotension—Doxorubicin—uterine cancer	0.000358	0.00038	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000357	0.00038	CcSEcCtD
Valganciclovir—Fatigue—Epirubicin—uterine cancer	0.000357	0.000379	CcSEcCtD
Valganciclovir—Pain—Epirubicin—uterine cancer	0.000354	0.000376	CcSEcCtD
Valganciclovir—Constipation—Epirubicin—uterine cancer	0.000354	0.000376	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000349	0.000371	CcSEcCtD
Valganciclovir—Insomnia—Doxorubicin—uterine cancer	0.000346	0.000368	CcSEcCtD
Valganciclovir—Paraesthesia—Doxorubicin—uterine cancer	0.000344	0.000365	CcSEcCtD
Valganciclovir—Dyspnoea—Doxorubicin—uterine cancer	0.000341	0.000363	CcSEcCtD
Valganciclovir—Feeling abnormal—Epirubicin—uterine cancer	0.000341	0.000362	CcSEcCtD
Valganciclovir—Somnolence—Doxorubicin—uterine cancer	0.00034	0.000362	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Epirubicin—uterine cancer	0.000338	0.00036	CcSEcCtD
Valganciclovir—Dyspepsia—Doxorubicin—uterine cancer	0.000337	0.000358	CcSEcCtD
Valganciclovir—Decreased appetite—Doxorubicin—uterine cancer	0.000333	0.000354	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000331	0.000351	CcSEcCtD
Valganciclovir—Fatigue—Doxorubicin—uterine cancer	0.00033	0.000351	CcSEcCtD
Valganciclovir—Urticaria—Epirubicin—uterine cancer	0.000329	0.000349	CcSEcCtD
Valganciclovir—Pain—Doxorubicin—uterine cancer	0.000327	0.000348	CcSEcCtD
Valganciclovir—Constipation—Doxorubicin—uterine cancer	0.000327	0.000348	CcSEcCtD
Valganciclovir—Body temperature increased—Epirubicin—uterine cancer	0.000327	0.000348	CcSEcCtD
Valganciclovir—Abdominal pain—Epirubicin—uterine cancer	0.000327	0.000348	CcSEcCtD
Valganciclovir—Feeling abnormal—Doxorubicin—uterine cancer	0.000316	0.000335	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000313	0.000333	CcSEcCtD
Valganciclovir—Hypersensitivity—Epirubicin—uterine cancer	0.000305	0.000324	CcSEcCtD
Valganciclovir—Urticaria—Doxorubicin—uterine cancer	0.000304	0.000323	CcSEcCtD
Valganciclovir—Abdominal pain—Doxorubicin—uterine cancer	0.000303	0.000322	CcSEcCtD
Valganciclovir—Body temperature increased—Doxorubicin—uterine cancer	0.000303	0.000322	CcSEcCtD
Valganciclovir—Asthenia—Epirubicin—uterine cancer	0.000297	0.000316	CcSEcCtD
Valganciclovir—Pruritus—Epirubicin—uterine cancer	0.000293	0.000311	CcSEcCtD
Valganciclovir—Diarrhoea—Epirubicin—uterine cancer	0.000283	0.000301	CcSEcCtD
Valganciclovir—Hypersensitivity—Doxorubicin—uterine cancer	0.000282	0.0003	CcSEcCtD
Valganciclovir—Asthenia—Doxorubicin—uterine cancer	0.000275	0.000292	CcSEcCtD
Valganciclovir—Dizziness—Epirubicin—uterine cancer	0.000274	0.000291	CcSEcCtD
Valganciclovir—Pruritus—Doxorubicin—uterine cancer	0.000271	0.000288	CcSEcCtD
Valganciclovir—Vomiting—Epirubicin—uterine cancer	0.000263	0.00028	CcSEcCtD
Valganciclovir—Diarrhoea—Doxorubicin—uterine cancer	0.000262	0.000278	CcSEcCtD
Valganciclovir—Dermatitis—Epirubicin—uterine cancer	0.000261	0.000277	CcSEcCtD
Valganciclovir—Headache—Epirubicin—uterine cancer	0.000259	0.000276	CcSEcCtD
Valganciclovir—Dizziness—Doxorubicin—uterine cancer	0.000253	0.000269	CcSEcCtD
Valganciclovir—Nausea—Epirubicin—uterine cancer	0.000246	0.000261	CcSEcCtD
Valganciclovir—Vomiting—Doxorubicin—uterine cancer	0.000243	0.000259	CcSEcCtD
Valganciclovir—Dermatitis—Doxorubicin—uterine cancer	0.000241	0.000256	CcSEcCtD
Valganciclovir—Headache—Doxorubicin—uterine cancer	0.00024	0.000255	CcSEcCtD
Valganciclovir—Nausea—Doxorubicin—uterine cancer	0.000227	0.000242	CcSEcCtD
